메뉴 건너뛰기




Volumn 2, Issue 4, 2008, Pages 363-384

Tau as a biomarker of neurodegenerative diseases

Author keywords

Alzheimer's disease; Biomarker; Microtubule associated Tau protein; Neuroflbriliary degeneration; Phosphorylation; Tauopathies

Indexed keywords

BIOLOGICAL MARKER; ISOPROTEIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; RNA; SERUM AMYLOID A; TAU PROTEIN;

EID: 54849428550     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/17520363.2.4.363     Document Type: Review
Times cited : (90)

References (196)
  • 2
    • 13944278863 scopus 로고    scopus 로고
    • A common inversion under selection in Europeans
    • Stefansson H, Helgason A, Thorleifsson G et al.: A common inversion under selection in Europeans. Nat. Genet. 37(2), 129-137 (2005).
    • (2005) Nat. Genet , vol.37 , Issue.2 , pp. 129-137
    • Stefansson, H.1    Helgason, A.2    Thorleifsson, G.3
  • 3
    • 1842419456 scopus 로고    scopus 로고
    • Microtubule-associated protein tau gene: A risk factor in human neurodegenerative diseases
    • Schraen-Maschke S, Dhaenens CM, Delacourte A, Sablonniere B: Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases. Neurobiol. Dis. 15(3), 449-460 (2004).
    • (2004) Neurobiol. Dis , vol.15 , Issue.3 , pp. 449-460
    • Schraen-Maschke, S.1    Dhaenens, C.M.2    Delacourte, A.3    Sablonniere, B.4
  • 4
    • 3042813452 scopus 로고    scopus 로고
    • The structure of the tau haplotype in controls and in progressive supranuclear palsy
    • Pittman AM, Myers AJ, Duckworth J et al.: The structure of the tau haplotype in controls and in progressive supranuclear palsy. Hum. Mol. Genet. 13(12), 1267-1274 (2004).
    • (2004) Hum. Mol. Genet , vol.13 , Issue.12 , pp. 1267-1274
    • Pittman, A.M.1    Myers, A.J.2    Duckworth, J.3
  • 5
    • 0028853922 scopus 로고
    • Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes
    • LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder LI: Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc. Natl Acad. Sci. USA 92(22), 10369-10373 (1995).
    • (1995) Proc. Natl Acad. Sci. USA , vol.92 , Issue.22 , pp. 10369-10373
    • LoPresti, P.1    Szuchet, S.2    Papasozomenos, S.C.3    Zinkowski, R.P.4    Binder, L.I.5
  • 6
    • 10944272640 scopus 로고    scopus 로고
    • Tau gene alternative splicing: Expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases
    • Andreadis A: Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim. Biophys. Acta 1739(2-3), 91-103 (2005).
    • (2005) Biochim. Biophys. Acta , vol.1739 , Issue.2-3 , pp. 91-103
    • Andreadis, A.1
  • 7
    • 34447124582 scopus 로고    scopus 로고
    • RNA and protein-dependent mechanisms in Tauopathies: Consequences for therapeutic strategies
    • Gallo JM, Noble W, Martin TR: RNA and protein-dependent mechanisms in Tauopathies: consequences for therapeutic strategies. Cell. Mol. Life Sci. 64(13), 1701-1714 (2007).
    • (2007) Cell. Mol. Life Sci , vol.64 , Issue.13 , pp. 1701-1714
    • Gallo, J.M.1    Noble, W.2    Martin, T.R.3
  • 8
    • 43249124363 scopus 로고    scopus 로고
    • Microtubule-associated protein Tau in development, degeneration and protection of neurons
    • Wang JZ, Liu F: Microtubule-associated protein Tau in development, degeneration and protection of neurons. Prog. Neurobiol. 85(2), 148-175 (2008).
    • (2008) Prog. Neurobiol , vol.85 , Issue.2 , pp. 148-175
    • Wang, J.Z.1    Liu, F.2
  • 9
    • 27844470590 scopus 로고    scopus 로고
    • Molecular motors implicated in the axonal transport of Tau and α-synuclein
    • Utton MA, Noble WJ, Hill JE, Anderton BH, Hanger DP: Molecular motors implicated in the axonal transport of Tau and α-synuclein. J. Cell. Sci. 118(Pt 20), 4645-4654 (2005).
    • (2005) J. Cell. Sci , vol.118 , Issue.PART 20 , pp. 4645-4654
    • Utton, M.A.1    Noble, W.J.2    Hill, J.E.3    Anderton, B.H.4    Hanger, D.P.5
  • 10
    • 35649028013 scopus 로고    scopus 로고
    • Interaction of Tau protein with the dynactin complex
    • Magnani E, Fan J, Gasparini L et al.: Interaction of Tau protein with the dynactin complex. EMBO J. 26(21), 4546-4554 (2007).
    • (2007) EMBO J , vol.26 , Issue.21 , pp. 4546-4554
    • Magnani, E.1    Fan, J.2    Gasparini, L.3
  • 11
    • 49649119504 scopus 로고    scopus 로고
    • Phosphorylation regulates Tau interactions with SH3 domains of phosphatidylinositol-3-kinase, phospholipase Cγ 1, GRB2 and SRC-family kinases
    • Reynolds CH, Garwood CJ, Wray S et al.: Phosphorylation regulates Tau interactions with SH3 domains of phosphatidylinositol-3-kinase, phospholipase Cγ 1, GRB2 and SRC-family kinases. J. Biol. Chem. 283(26), 18177-18186 (2008).
    • (2008) J. Biol. Chem , vol.283 , Issue.26 , pp. 18177-18186
    • Reynolds, C.H.1    Garwood, C.J.2    Wray, S.3
  • 12
    • 0036469248 scopus 로고    scopus 로고
    • Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein Tau
    • Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J: Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein Tau. J. Neurosci. 22(3), 698-707 (2002).
    • (2002) J. Neurosci , vol.22 , Issue.3 , pp. 698-707
    • Klein, C.1    Kramer, E.M.2    Cardine, A.M.3    Schraven, B.4    Brandt, R.5    Trotter, J.6
  • 13
    • 46749151737 scopus 로고    scopus 로고
    • Tau isoform expression and regulation in human cortical neurons
    • Deshpande A, Win KM, Busciglio J: Tau isoform expression and regulation in human cortical neurons. Faseb J. 22(7), 2357-2367 (2008).
    • (2008) Faseb J , vol.22 , Issue.7 , pp. 2357-2367
    • Deshpande, A.1    Win, K.M.2    Busciglio, J.3
  • 14
    • 0024745894 scopus 로고
    • Multiple isoforms of human microtubule-associated protein Tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
    • Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA: Multiple isoforms of human microtubule-associated protein Tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3(4), 519-526 (1989).
    • (1989) Neuron , vol.3 , Issue.4 , pp. 519-526
    • Goedert, M.1    Spillantini, M.G.2    Jakes, R.3    Rutherford, D.4    Crowther, R.A.5
  • 15
    • 34548191034 scopus 로고    scopus 로고
    • Novel phosphorylation sites in Tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis
    • Hanger DP, Byers HL, Wray S et al.: Novel phosphorylation sites in Tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J. Biol. Chem. 282(32), 23645-23654 (2007).
    • (2007) J. Biol. Chem , vol.282 , Issue.32 , pp. 23645-23654
    • Hanger, D.P.1    Byers, H.L.2    Wray, S.3
  • 16
    • 43449128899 scopus 로고    scopus 로고
    • Sergeant N, Bretteville A, Hamdane M et al.: Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev. Proteomics 5(2), 207-224 (2008).
    • Sergeant N, Bretteville A, Hamdane M et al.: Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev. Proteomics 5(2), 207-224 (2008).
  • 17
    • 10944223484 scopus 로고    scopus 로고
    • Tau protein as a differential biomarker of tauopathies
    • Sergeant N, Delacourte A, Buee L: Tau protein as a differential biomarker of tauopathies. Biochim. Biophys. Acta 1739(2-3), 179-197 (2005).
    • (2005) Biochim. Biophys. Acta , vol.1739 , Issue.2-3 , pp. 179-197
    • Sergeant, N.1    Delacourte, A.2    Buee, L.3
  • 18
    • 5444273804 scopus 로고    scopus 로고
    • MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons
    • Mandelkow EM, Thies E, Trinczek B, Biernat J, Mandelkow E: MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J. Cell Biol. 167(1), 99-110 (2004).
    • (2004) J. Cell Biol , vol.167 , Issue.1 , pp. 99-110
    • Mandelkow, E.M.1    Thies, E.2    Trinczek, B.3    Biernat, J.4    Mandelkow, E.5
  • 19
    • 12144288564 scopus 로고    scopus 로고
    • Phosphorylation of Tau by fyn: Implications for Alzheimer's disease
    • Lee G, Thangavel R, Sharma VM et al.: Phosphorylation of Tau by fyn: implications for Alzheimer's disease. J. Neurosci. 24(9), 2304-2312 (2004).
    • (2004) J. Neurosci , vol.24 , Issue.9 , pp. 2304-2312
    • Lee, G.1    Thangavel, R.2    Sharma, V.M.3
  • 20
    • 0036138048 scopus 로고    scopus 로고
    • Rapid tyrosine phosphorylation of neuronal proteins including Tau and focal adhesion kinase in response to amyloid-β peptide exposure: Involvement of Src family protein kinases
    • Williamson R, Scales T, Clark BR et al.: Rapid tyrosine phosphorylation of neuronal proteins including Tau and focal adhesion kinase in response to amyloid-β peptide exposure: involvement of Src family protein kinases. J. Neurosci. 22(1), 10-20 (2002).
    • (2002) J. Neurosci , vol.22 , Issue.1 , pp. 10-20
    • Williamson, R.1    Scales, T.2    Clark, B.R.3
  • 21
    • 22244475384 scopus 로고    scopus 로고
    • Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament Tau and in fetal Tau with c-Abl as the candidate tyrosine kinase
    • Derkinderen P, Scales TM, Hanger DP et al.: Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament Tau and in fetal Tau with c-Abl as the candidate tyrosine kinase. J. Neurosci. 25(28), 6584-6593 (2005).
    • (2005) J. Neurosci , vol.25 , Issue.28 , pp. 6584-6593
    • Derkinderen, P.1    Scales, T.M.2    Hanger, D.P.3
  • 22
    • 33748323156 scopus 로고    scopus 로고
    • A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism
    • Koolen DA, Vissers LE, Pfundt R et al.: A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat. Genet. 38(9), 999-1001 (2006).
    • (2006) Nat. Genet , vol.38 , Issue.9 , pp. 999-1001
    • Koolen, D.A.1    Vissers, L.E.2    Pfundt, R.3
  • 23
    • 33748333194 scopus 로고    scopus 로고
    • Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome
    • Sharp AJ, Hansen S, Selzer RR et al.: Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat. Genet. 38(9), 1038-1042 (2006).
    • (2006) Nat. Genet , vol.38 , Issue.9 , pp. 1038-1042
    • Sharp, A.J.1    Hansen, S.2    Selzer, R.R.3
  • 24
    • 33744987916 scopus 로고    scopus 로고
    • A 17q21.31 microdeletion encompassing the MAPT gene in a mentally impaired patient
    • Varela MC, Krepischi-Santos AC, Paz JA et al.: A 17q21.31 microdeletion encompassing the MAPT gene in a mentally impaired patient. Cytogenet. Genome Res. 114(1), 89-92 (2006).
    • (2006) Cytogenet. Genome Res , vol.114 , Issue.1 , pp. 89-92
    • Varela, M.C.1    Krepischi-Santos, A.C.2    Paz, J.A.3
  • 25
    • 33748300645 scopus 로고    scopus 로고
    • Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability
    • Shaw-Smith C, Pittman AM, Willatt L et al.: Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat. Genet. 38(9), 1032-1037 (2006).
    • (2006) Nat. Genet , vol.38 , Issue.9 , pp. 1032-1037
    • Shaw-Smith, C.1    Pittman, A.M.2    Willatt, L.3
  • 26
    • 34447309023 scopus 로고    scopus 로고
    • A 17q21.31 microduplication, reciprocal to the newly described 17q21.31 microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features
    • Kirchhoff M, Bisgaard AM, Duno M, Hansen FJ, Schwartz M: A 17q21.31 microduplication, reciprocal to the newly described 17q21.31 microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features. Eur. J. Med. Genet. 50(4), 256-263 (2007).
    • (2007) Eur. J. Med. Genet , vol.50 , Issue.4 , pp. 256-263
    • Kirchhoff, M.1    Bisgaard, A.M.2    Duno, M.3    Hansen, F.J.4    Schwartz, M.5
  • 28
    • 42249085980 scopus 로고    scopus 로고
    • Refining frontotemporal dementia with parkinsonism linked to chromosome 17: Introducing FTDP-17 (MAPT) and FTDP-17 (PGRN)
    • Boeve BF, Hutton M: Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch. Neurol. 65(4), 460-464 (2008).
    • (2008) Arch. Neurol , vol.65 , Issue.4 , pp. 460-464
    • Boeve, B.F.1    Hutton, M.2
  • 29
    • 34250335127 scopus 로고    scopus 로고
    • Functional MAPT haplotypes: Bridging the gap between genotype and neuropathology
    • Caffrey TM, Wade-Martins R: Functional MAPT haplotypes: bridging the gap between genotype and neuropathology. Neurobiol. Dis. 27(1), 1-10 (2007).
    • (2007) Neurobiol. Dis , vol.27 , Issue.1 , pp. 1-10
    • Caffrey, T.M.1    Wade-Martins, R.2
  • 30
    • 48249102700 scopus 로고    scopus 로고
    • Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The GenePD Study
    • Tobin JE, Latourelle JC, Lew MF et al.: Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology 71(1), 28-34 (2008).
    • (2008) Neurology , vol.71 , Issue.1 , pp. 28-34
    • Tobin, J.E.1    Latourelle, J.C.2    Lew, M.F.3
  • 31
    • 35148829539 scopus 로고    scopus 로고
    • Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease
    • Zabetian CP, Hutter CM, Factor SA et al.: Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Ann. Neurol. 62(2), 137-144 (2007).
    • (2007) Ann. Neurol , vol.62 , Issue.2 , pp. 137-144
    • Zabetian, C.P.1    Hutter, C.M.2    Factor, S.A.3
  • 32
    • 24644502474 scopus 로고    scopus 로고
    • Linkage disequilibrium fine mapping and haplotype association analysis of the Tau gene in progressive supranuclear palsy and corticobasal degeneration
    • Pittman AM, Myers AJ, Abou-Sleiman P et al.: Linkage disequilibrium fine mapping and haplotype association analysis of the Tau gene in progressive supranuclear palsy and corticobasal degeneration. J. Med. Genet. 42(11), 837-846 (2005).
    • (2005) J. Med. Genet , vol.42 , Issue.11 , pp. 837-846
    • Pittman, A.M.1    Myers, A.J.2    Abou-Sleiman, P.3
  • 33
    • 26444463460 scopus 로고    scopus 로고
    • The H1c haplotype at the MAPT locus is associated with Alzheimer's disease
    • Myers AJ, Kaleem M, Marlowe L et al.: The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum. Mol. Genet. 14(16), 2399-2404 (2005).
    • (2005) Hum. Mol. Genet , vol.14 , Issue.16 , pp. 2399-2404
    • Myers, A.J.1    Kaleem, M.2    Marlowe, L.3
  • 34
    • 33749499157 scopus 로고    scopus 로고
    • HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, Tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin
    • Mukherjee O, Pastor P, Cairns NJ et al.: HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, Tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann. Neurol. 60(3), 314-322 (2006).
    • (2006) Ann. Neurol , vol.60 , Issue.3 , pp. 314-322
    • Mukherjee, O.1    Pastor, P.2    Cairns, N.J.3
  • 35
    • 27744488802 scopus 로고    scopus 로고
    • High-density SNP haplotyping suggests altered regulation of Tau gene expression in progressive supranuclear palsy
    • Rademakers R, Melquist S, Cruts M et al.: High-density SNP haplotyping suggests altered regulation of Tau gene expression in progressive supranuclear palsy. Hum. Mol. Genet. 14(21), 3281-3292 (2005).
    • (2005) Hum. Mol. Genet , vol.14 , Issue.21 , pp. 3281-3292
    • Rademakers, R.1    Melquist, S.2    Cruts, M.3
  • 37
    • 33847178181 scopus 로고    scopus 로고
    • The MAPT H1c risk haplotype is associated with increased expression of Tau and especially of 4 repeat containing transcripts
    • Myers AJ, Pittman AM, Zhao AS et al.: The MAPT H1c risk haplotype is associated with increased expression of Tau and especially of 4 repeat containing transcripts. Neurobiol. Dis. 25(3), 561-570 (2007).
    • (2007) Neurobiol. Dis , vol.25 , Issue.3 , pp. 561-570
    • Myers, A.J.1    Pittman, A.M.2    Zhao, A.S.3
  • 39
    • 36749028147 scopus 로고    scopus 로고
    • Brain Tau expression and correlation with the H1/H1 Tau genotype in frontotemporal lobar degeneration patients
    • Llado A, Ezquerra M, Gaig C, Sanchez-Valle R, Tolosa E, Molinuevo JL: Brain Tau expression and correlation with the H1/H1 Tau genotype in frontotemporal lobar degeneration patients. J. Neural Transm. 114(12), 1585-1588 (2007).
    • (2007) J. Neural Transm , vol.114 , Issue.12 , pp. 1585-1588
    • Llado, A.1    Ezquerra, M.2    Gaig, C.3    Sanchez-Valle, R.4    Tolosa, E.5    Molinuevo, J.L.6
  • 40
    • 35148866228 scopus 로고    scopus 로고
    • Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease
    • Goris A, Williams-Gray CH, Clark GR et al.: Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann. Neurol. 62(2), 145-153 (2007).
    • (2007) Ann. Neurol , vol.62 , Issue.2 , pp. 145-153
    • Goris, A.1    Williams-Gray, C.H.2    Clark, G.R.3
  • 41
    • 34548207303 scopus 로고    scopus 로고
    • Cerebral involvement in myotonic dystrophies
    • Meola G, Sansone V: Cerebral involvement in myotonic dystrophies. Muscle Nerve 36(3), 294-306 (2007).
    • (2007) Muscle Nerve , vol.36 , Issue.3 , pp. 294-306
    • Meola, G.1    Sansone, V.2
  • 43
    • 33748373580 scopus 로고    scopus 로고
    • RNA-mediated neuromuscular disorders
    • Ranum LP, Cooper TA: RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci. 29, 259-277 (2006).
    • (2006) Annu. Rev. Neurosci , vol.29 , pp. 259-277
    • Ranum, L.P.1    Cooper, T.A.2
  • 44
    • 0029822936 scopus 로고    scopus 로고
    • Specific Tau variants in the brains of patients with myotonic dystrophy
    • Vermersch P, Sergeant N, Ruchoux MM et al.: Specific Tau variants in the brains of patients with myotonic dystrophy. Neurology 47(3), 711-717 (1996).
    • (1996) Neurology , vol.47 , Issue.3 , pp. 711-717
    • Vermersch, P.1    Sergeant, N.2    Ruchoux, M.M.3
  • 45
    • 34548263375 scopus 로고    scopus 로고
    • Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy
    • Kuyumcu-Martinez NM, Cooper TA: Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy. Prog. Mol. Subcell. Biol. 44, 133-159 (2006).
    • (2006) Prog. Mol. Subcell. Biol , vol.44 , pp. 133-159
    • Kuyumcu-Martinez, N.M.1    Cooper, T.A.2
  • 46
    • 11044233708 scopus 로고    scopus 로고
    • Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons
    • Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA: Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 13(24), 3079-3088 (2004).
    • (2004) Hum. Mol. Genet , vol.13 , Issue.24 , pp. 3079-3088
    • Jiang, H.1    Mankodi, A.2    Swanson, M.S.3    Moxley, R.T.4    Thornton, C.A.5
  • 47
    • 0034782506 scopus 로고    scopus 로고
    • Dysregulation of human brain microtubule-associated Tau mRNA maturation in myotonic dystrophy type 1
    • Sergeant N, Sablonniere B, Schraen-Maschke S et al.: Dysregulation of human brain microtubule-associated Tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 10(19), 2143-2155 (2001).
    • (2001) Hum. Mol. Genet , vol.10 , Issue.19 , pp. 2143-2155
    • Sergeant, N.1    Sablonniere, B.2    Schraen-Maschke, S.3
  • 48
    • 28044436700 scopus 로고    scopus 로고
    • Similar brain Tau pathology in DM2/PROMM and DM1/Steinert disease
    • Maurage CA, Udd B, Ruchoux MM et al.: Similar brain Tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology 65(10), 1636-1638 (2005).
    • (2005) Neurology , vol.65 , Issue.10 , pp. 1636-1638
    • Maurage, C.A.1    Udd, B.2    Ruchoux, M.M.3
  • 49
    • 41349110876 scopus 로고    scopus 로고
    • Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats
    • Dhaenens CM, Schraen-Maschke S, Tran H et al.: Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats. Exp. Neurol. 210(2), 467-478 (2008).
    • (2008) Exp. Neurol , vol.210 , Issue.2 , pp. 467-478
    • Dhaenens, C.M.1    Schraen-Maschke, S.2    Tran, H.3
  • 50
    • 33846318219 scopus 로고    scopus 로고
    • Myotonic dystrophy: Emerging mechanisms for DM1 and DM2
    • Cho DH, Tapscott SJ: Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim. Biophys. Acta 1772(2), 195-204 (2007).
    • (2007) Biochim. Biophys. Acta , vol.1772 , Issue.2 , pp. 195-204
    • Cho, D.H.1    Tapscott, S.J.2
  • 51
    • 1342347848 scopus 로고    scopus 로고
    • Stable-Tau overexpression in human neuroblastoma cells: An open door for explaining neuronal death in tauopathies
    • Delobel P, Mailliot C, Hamdane M et al.: Stable-Tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies. Ann. NY Acad. Sci. 1010, 623-634 (2003).
    • (2003) Ann. NY Acad. Sci , vol.1010 , pp. 623-634
    • Delobel, P.1    Mailliot, C.2    Hamdane, M.3
  • 52
    • 0036685608 scopus 로고    scopus 로고
    • Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration
    • Higuchi M, Ishihara T, Zhang B et al.: Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron 35(3), 433-446 (2002).
    • (2002) Neuron , vol.35 , Issue.3 , pp. 433-446
    • Higuchi, M.1    Ishihara, T.2    Zhang, B.3
  • 53
    • 34948883291 scopus 로고    scopus 로고
    • Increase in the relative expression of Tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains
    • Ingelsson M, Ramasamy K, Russ CB et al.: Increase in the relative expression of Tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. Acta Neuropathol. 114(5), 471-479 (2007).
    • (2007) Acta Neuropathol , vol.114 , Issue.5 , pp. 471-479
    • Ingelsson, M.1    Ramasamy, K.2    Russ, C.B.3
  • 54
    • 33646806069 scopus 로고    scopus 로고
    • Three-repeat Tau 69 is a major Tau isoform in laser-microdissected Pick bodies
    • Ohkubo T, Sakasegawa Y, Toda H et al.: Three-repeat Tau 69 is a major Tau isoform in laser-microdissected Pick bodies. Amyloid 13(1), 1-5 (2006).
    • (2006) Amyloid , vol.13 , Issue.1 , pp. 1-5
    • Ohkubo, T.1    Sakasegawa, Y.2    Toda, H.3
  • 55
    • 33645107783 scopus 로고    scopus 로고
    • The alternative splicing of Tau exon 10 and its regulatory proteins CLK2 and TRA2-β1 changes in sporadic Alzheimer's disease
    • Glatz DC, Rujescu D, Tang Y et al.: The alternative splicing of Tau exon 10 and its regulatory proteins CLK2 and TRA2-β1 changes in sporadic Alzheimer's disease. J. Neurochem. 96(3), 635-644 (2006).
    • (2006) J. Neurochem , vol.96 , Issue.3 , pp. 635-644
    • Glatz, D.C.1    Rujescu, D.2    Tang, Y.3
  • 56
    • 0038050650 scopus 로고    scopus 로고
    • Different immunoreactivities of the microtubule-binding region of Tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration
    • Arai T, Ikeda K, Akiyama H et al.: Different immunoreactivities of the microtubule-binding region of Tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 105(5), 489-498 (2003).
    • (2003) Acta Neuropathol , vol.105 , Issue.5 , pp. 489-498
    • Arai, T.1    Ikeda, K.2    Akiyama, H.3
  • 57
    • 1842451983 scopus 로고    scopus 로고
    • Alterations in human Tau transcripts correlate with those of neurofilament in sporadic tauopathies
    • Umeda Y, Taniguchi S, Arima K et al.: Alterations in human Tau transcripts correlate with those of neurofilament in sporadic tauopathies. Neurosci. Lett. 359(3), 151-154 (2004).
    • (2004) Neurosci. Lett , vol.359 , Issue.3 , pp. 151-154
    • Umeda, Y.1    Taniguchi, S.2    Arima, K.3
  • 58
    • 33749152589 scopus 로고    scopus 로고
    • No alteration in Tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain
    • Ingelsson M, Ramasamy K, Cantuti-Castelvetri I et al.: No alteration in Tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain. Acta Neuropathol. 112(4), 439-449 (2006).
    • (2006) Acta Neuropathol , vol.112 , Issue.4 , pp. 439-449
    • Ingelsson, M.1    Ramasamy, K.2    Cantuti-Castelvetri, I.3
  • 60
    • 20044367108 scopus 로고    scopus 로고
    • Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human Tau isoforms
    • Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P: Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human Tau isoforms. J. Neurosci. 25(22), 5446-5454 (2005).
    • (2005) J. Neurosci , vol.25 , Issue.22 , pp. 5446-5454
    • Andorfer, C.1    Acker, C.M.2    Kress, Y.3    Hof, P.R.4    Duff, K.5    Davies, P.6
  • 61
    • 22344438508 scopus 로고    scopus 로고
    • Tau suppression in a neurodegenerative mouse model improves memory function
    • Santacruz K, Lewis J, Spires T et al.: Tau suppression in a neurodegenerative mouse model improves memory function. Science 309(5733), 476-481 (2005).
    • (2005) Science , vol.309 , Issue.5733 , pp. 476-481
    • Santacruz, K.1    Lewis, J.2    Spires, T.3
  • 62
    • 17044435830 scopus 로고    scopus 로고
    • Tau phosphorylation in Alzheimer's disease: Pathogen or protector?
    • Lee HG, Perry G, Moreira PI et al.: Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends Mol. Med. 11(4), 164-169 (2005).
    • (2005) Trends Mol. Med , vol.11 , Issue.4 , pp. 164-169
    • Lee, H.G.1    Perry, G.2    Moreira, P.I.3
  • 63
    • 7244236320 scopus 로고    scopus 로고
    • Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
    • Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S: Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431(7010), 805-810 (2004).
    • (2004) Nature , vol.431 , Issue.7010 , pp. 805-810
    • Arrasate, M.1    Mitra, S.2    Schweitzer, E.S.3    Segal, M.R.4    Finkbeiner, S.5
  • 64
    • 0035958642 scopus 로고    scopus 로고
    • Tauopathy in Drosophila: Neurodegeneration without neurofibrillary tangles
    • Wittmann CW, Wszolek MF, Shulman JM et al.: Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293(5530), 711-714 (2001).
    • (2001) Science , vol.293 , Issue.5530 , pp. 711-714
    • Wittmann, C.W.1    Wszolek, M.F.2    Shulman, J.M.3
  • 65
    • 13644268449 scopus 로고    scopus 로고
    • Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice
    • Terwel D, Lasrado R, Snauwaert J et al.: Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J. Biol. Chem. 280(5), 3963-3973 (2005).
    • (2005) J. Biol. Chem , vol.280 , Issue.5 , pp. 3963-3973
    • Terwel, D.1    Lasrado, R.2    Snauwaert, J.3
  • 66
    • 44849144122 scopus 로고    scopus 로고
    • I1PP2A affects Tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A
    • Chen S, Li B, Grundke-Iqbal I, Iqbal K: I1PP2A affects Tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A. J. Biol. Chem. 283(16), 10513-10521 (2008).
    • (2008) J. Biol. Chem , vol.283 , Issue.16 , pp. 10513-10521
    • Chen, S.1    Li, B.2    Grundke-Iqbal, I.3    Iqbal, K.4
  • 67
    • 0036937699 scopus 로고    scopus 로고
    • Specific Tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease
    • Augustinack JC, Schneider A, Mandelkow EM, Hyman BT: Specific Tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 103(1), 26-35 (2002).
    • (2002) Acta Neuropathol , vol.103 , Issue.1 , pp. 26-35
    • Augustinack, J.C.1    Schneider, A.2    Mandelkow, E.M.3    Hyman, B.T.4
  • 68
    • 33748715165 scopus 로고    scopus 로고
    • Sequential phosphorylation of Tau protein by cAMP-dependent protein kinase and SAPK4/p38delta or JNK2 in the presence of heparin generates the AT100 epitope
    • Yoshida H, Goedert M: Sequential phosphorylation of Tau protein by cAMP-dependent protein kinase and SAPK4/p38delta or JNK2 in the presence of heparin generates the AT100 epitope. J. Neurochem. 99(1), 154-164 (2006).
    • (2006) J. Neurochem , vol.99 , Issue.1 , pp. 154-164
    • Yoshida, H.1    Goedert, M.2
  • 69
    • 0029670872 scopus 로고    scopus 로고
    • Specific pathological Tau protein variants characterize Pick's disease
    • Delacourte A, Robitaille Y, Sergeant N et al.: Specific pathological Tau protein variants characterize Pick's disease. J. Neuropathol. Exp. Neurol. 55(2), 159-168 (1996).
    • (1996) J. Neuropathol. Exp. Neurol , vol.55 , Issue.2 , pp. 159-168
    • Delacourte, A.1    Robitaille, Y.2    Sergeant, N.3
  • 70
    • 0029850476 scopus 로고    scopus 로고
    • Pick's disease: Hyperphosphorylated Tau protein segregates to the somatoaxonal compartment
    • Probst A, Tolnay M, Langui D, Goedert M, Spillantini MG: Pick's disease: hyperphosphorylated Tau protein segregates to the somatoaxonal compartment. Acta Neuropathol. 92(6), 588-596 (1996).
    • (1996) Acta Neuropathol , vol.92 , Issue.6 , pp. 588-596
    • Probst, A.1    Tolnay, M.2    Langui, D.3    Goedert, M.4    Spillantini, M.G.5
  • 71
    • 33746652117 scopus 로고    scopus 로고
    • Alzheimer's disease-like Tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated Tau transgenic mouse without any motor deficits
    • Schindowski K, Bretteville A, Leroy K et al.: Alzheimer's disease-like Tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated Tau transgenic mouse without any motor deficits. Am. J. Pathol. 169(2), 599-616 (2006).
    • (2006) Am. J. Pathol , vol.169 , Issue.2 , pp. 599-616
    • Schindowski, K.1    Bretteville, A.2    Leroy, K.3
  • 72
    • 0032894121 scopus 로고    scopus 로고
    • The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease
    • Delacourte A, David JP, Sergeant N et al.: The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52(6), 1158-1165 (1999).
    • (1999) Neurology , vol.52 , Issue.6 , pp. 1158-1165
    • Delacourte, A.1    David, J.P.2    Sergeant, N.3
  • 73
    • 1042266624 scopus 로고    scopus 로고
    • CHIP-Hsc70 complex ubiquitinates phosphorylated Tau and enhances cell survival
    • Shimura H, Schwartz D, Gygi SP, Kosik KS: CHIP-Hsc70 complex ubiquitinates phosphorylated Tau and enhances cell survival. J. Biol. Chem. 279(6), 4869-4876 (2004).
    • (2004) J. Biol. Chem , vol.279 , Issue.6 , pp. 4869-4876
    • Shimura, H.1    Schwartz, D.2    Gygi, S.P.3    Kosik, K.S.4
  • 74
    • 0033928035 scopus 로고    scopus 로고
    • The neuronal microtubule-associated protein Tau is a substrate for caspase-3 and an effector of apoptosis
    • Fasulo L, Ugolini G, Visintin M et al.: The neuronal microtubule-associated protein Tau is a substrate for caspase-3 and an effector of apoptosis. J. Neurochem. 75(2), 624-633 (2000).
    • (2000) J. Neurochem , vol.75 , Issue.2 , pp. 624-633
    • Fasulo, L.1    Ugolini, G.2    Visintin, M.3
  • 75
    • 0041689948 scopus 로고    scopus 로고
    • Caspase cleavage of Tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
    • Gamblin TC, Chen F, Zambrano A et al.: Caspase cleavage of Tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl Acad. Sci. USA 100(17), 10032-10037 (2003).
    • (2003) Proc. Natl Acad. Sci. USA , vol.100 , Issue.17 , pp. 10032-10037
    • Gamblin, T.C.1    Chen, F.2    Zambrano, A.3
  • 76
    • 0028785672 scopus 로고
    • Calpain-induced proteolysis of normal human Tau and Tau associated with paired helical filaments
    • Yang LS, Ksiezak-Reding H: Calpain-induced proteolysis of normal human Tau and Tau associated with paired helical filaments. Eur. J. Biochem. 233(1), 9-17 (1995).
    • (1995) Eur. J. Biochem , vol.233 , Issue.1 , pp. 9-17
    • Yang, L.S.1    Ksiezak-Reding, H.2
  • 78
    • 33646080573 scopus 로고    scopus 로고
    • Pseudophosphorylation of Tau at serine 422 inhibits caspase cleavage: In vitro evidence and implications for tangle formation in vivo
    • Guillozet-Bongaarts AL, Cahill ME, Cryns VL, Reynolds MR, Berry RW, Binder LI: Pseudophosphorylation of Tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo. J. Neurochem. 97(4), 1005-1014 (2006).
    • (2006) J. Neurochem , vol.97 , Issue.4 , pp. 1005-1014
    • Guillozet-Bongaarts, A.L.1    Cahill, M.E.2    Cryns, V.L.3    Reynolds, M.R.4    Berry, R.W.5    Binder, L.I.6
  • 79
    • 15244347753 scopus 로고    scopus 로고
    • Apoptotic effect of caspase-3 cleaved Tau in hippocampal neurons and its potentiation by Tau FTDP-mutation N279K
    • Fasulo L, Ugolini G, Cattaneo A: Apoptotic effect of caspase-3 cleaved Tau in hippocampal neurons and its potentiation by Tau FTDP-mutation N279K. J. Alzheimers Dis. 7(1), 3-13 (2005).
    • (2005) J. Alzheimers Dis , vol.7 , Issue.1 , pp. 3-13
    • Fasulo, L.1    Ugolini, G.2    Cattaneo, A.3
  • 83
    • 0038291981 scopus 로고    scopus 로고
    • Conformational changes and truncation of Tau protein during tangle evolution in Alzheimer's disease
    • Garcia-Sierra F, Ghoshal N, Quinn B, Berry RW, Binder LI: Conformational changes and truncation of Tau protein during tangle evolution in Alzheimer's disease. J. Alzheimers Dis. 5(2), 65-77 (2003).
    • (2003) J. Alzheimers Dis , vol.5 , Issue.2 , pp. 65-77
    • Garcia-Sierra, F.1    Ghoshal, N.2    Quinn, B.3    Berry, R.W.4    Binder, L.I.5
  • 84
    • 44649100169 scopus 로고    scopus 로고
    • Direct analysis of Tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved Tau containing four microtubule-binding repeats
    • Wray S, Saxton M, Anderton BH, Hanger DP: Direct analysis of Tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved Tau containing four microtubule-binding repeats. J. Neurochem. (2008)
    • (2008) J. Neurochem
    • Wray, S.1    Saxton, M.2    Anderton, B.H.3    Hanger, D.P.4
  • 85
    • 0026543843 scopus 로고
    • Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue
    • Yamada T, McGeer PL, McGeer EG: Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci. Lett. 135(1), 99-102 (1992).
    • (1992) Neurosci. Lett , vol.135 , Issue.1 , pp. 99-102
    • Yamada, T.1    McGeer, P.L.2    McGeer, E.G.3
  • 86
    • 0025609024 scopus 로고
    • Oligodendroglial microtubular masses: An abnormality observed in some human neurodegenerative diseases
    • Yamada T, McGeer PL: Oligodendroglial microtubular masses: an abnormality observed in some human neurodegenerative diseases. Neurosci. Lett. 120(2), 163-166 (1990).
    • (1990) Neurosci. Lett , vol.120 , Issue.2 , pp. 163-166
    • Yamada, T.1    McGeer, P.L.2
  • 87
    • 0028246505 scopus 로고
    • Corticobasal degeneration: Etiopathological significance of the cytoskeletal alterations
    • Wakabayashi K, Oyanagi K, Makifuchi T et al.: Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol. 87(6), 545-553 (1994).
    • (1994) Acta Neuropathol , vol.87 , Issue.6 , pp. 545-553
    • Wakabayashi, K.1    Oyanagi, K.2    Makifuchi, T.3
  • 88
    • 0032886469 scopus 로고    scopus 로고
    • Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease
    • Komori T: Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol. 9(4), 663-679 (1999).
    • (1999) Brain Pathol , vol.9 , Issue.4 , pp. 663-679
    • Komori, T.1
  • 89
    • 0026700341 scopus 로고
    • Molecular pathology of Alzheimer's disease in sporadic and familial Alzheimer's disease with mutations in the amyloid precursor protein
    • Hanger DP, Mann DM, Neary D, Anderton BH: Molecular pathology of Alzheimer's disease in sporadic and familial Alzheimer's disease with mutations in the amyloid precursor protein. Biochem. Soc. Trans. 20(3), 642-645 (1992).
    • (1992) Biochem. Soc. Trans , vol.20 , Issue.3 , pp. 642-645
    • Hanger, D.P.1    Mann, D.M.2    Neary, D.3    Anderton, B.H.4
  • 90
    • 0030748399 scopus 로고    scopus 로고
    • Different distribution of phosphorylated Tau protein isoforms in Alzheimer's and Pick's diseases
    • Sergeant N, David JP, Lefranc D, Vermersch P, Wattez A, Delacourte A: Different distribution of phosphorylated Tau protein isoforms in Alzheimer's and Pick's diseases. FEBS Lett. 412(3), 578-582 (1997).
    • (1997) FEBS Lett , vol.412 , Issue.3 , pp. 578-582
    • Sergeant, N.1    David, J.P.2    Lefranc, D.3    Vermersch, P.4    Wattez, A.5    Delacourte, A.6
  • 91
    • 0026595846 scopus 로고
    • Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms
    • Goedert M, Spillantini MG, Cairns NJ, Crowther RA: Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8(1), 159-168 (1992).
    • (1992) Neuron , vol.8 , Issue.1 , pp. 159-168
    • Goedert, M.1    Spillantini, M.G.2    Cairns, N.J.3    Crowther, R.A.4
  • 92
    • 0033009603 scopus 로고    scopus 로고
    • Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively 'exon 10' isoforms
    • Sergeant N, Wattez A, Delacourte A: Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively 'exon 10' isoforms. J. Neurochem. 72(3), 1243-1249 (1999).
    • (1999) J. Neurochem , vol.72 , Issue.3 , pp. 1243-1249
    • Sergeant, N.1    Wattez, A.2    Delacourte, A.3
  • 93
    • 0036938326 scopus 로고    scopus 로고
    • Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of Tau protein isoforms
    • Tolnay M, Sergeant N, Ghestem A: Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of Tau protein isoforms. Acta Neuropathol. 104(4), 425-434 (2002).
    • (2002) Acta Neuropathol , vol.104 , Issue.4 , pp. 425-434
    • Tolnay, M.1    Sergeant, N.2    Ghestem, A.3
  • 94
    • 34447096691 scopus 로고    scopus 로고
    • Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration
    • Cairns NJ, Bigio EH, Mackenzie IR et al.: Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 114(1), 5-22 (2007).
    • (2007) Acta Neuropathol , vol.114 , Issue.1 , pp. 5-22
    • Cairns, N.J.1    Bigio, E.H.2    Mackenzie, I.R.3
  • 96
    • 0027374233 scopus 로고
    • Detection of Tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay
    • Vandermeeren M, Mercken M, Vanmechelen E et al.: Detection of Tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J. Neurochem. 61(5), 1828-1834 (1993).
    • (1993) J. Neurochem , vol.61 , Issue.5 , pp. 1828-1834
    • Vandermeeren, M.1    Mercken, M.2    Vanmechelen, E.3
  • 97
    • 0037315940 scopus 로고    scopus 로고
    • Differentiation of geriatric major depression from Alzheimer's disease with CSF Tau protein phosphorylated at threonine 231
    • Buerger K, Zinkowski R, Teipel SJ et al.: Differentiation of geriatric major depression from Alzheimer's disease with CSF Tau protein phosphorylated at threonine 231. Am. J. Psychiatry 160(2), 376-379 (2003).
    • (2003) Am. J. Psychiatry , vol.160 , Issue.2 , pp. 376-379
    • Buerger, K.1    Zinkowski, R.2    Teipel, S.J.3
  • 98
    • 7444253126 scopus 로고    scopus 로고
    • Cerebrospinal fluid protein biomarkers for Alzheimer's disease
    • Blennow K: Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx 1(2), 213-225 (2004).
    • (2004) NeuroRx , vol.1 , Issue.2 , pp. 213-225
    • Blennow, K.1
  • 99
    • 0042591226 scopus 로고    scopus 로고
    • CSF markers for pathogenic processes in Alzheimer's disease: Diagnostic implications and use in clinical neurochemistry
    • Blennow K, Vanmechelen E: CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry. Brain Res. Bull. 61(3), 235-242 (2003).
    • (2003) Brain Res. Bull , vol.61 , Issue.3 , pp. 235-242
    • Blennow, K.1    Vanmechelen, E.2
  • 100
    • 0034741554 scopus 로고    scopus 로고
    • Tau and Aβ42 in cerebrospinal fluid from healthy adults 21-93 years of age: Establishment of reference values
    • Sjogren M, Vanderstichele H, Agren H et al.: Tau and Aβ42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin. Chem. 47(10), 1776-1781 (2001).
    • (2001) Clin. Chem , vol.47 , Issue.10 , pp. 1776-1781
    • Sjogren, M.1    Vanderstichele, H.2    Agren, H.3
  • 101
    • 0346124139 scopus 로고    scopus 로고
    • Cerebrospinal fluid Tau and β-amyloid: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
    • Clark CM, Xie S, Chittams J et al.: Cerebrospinal fluid Tau and β-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch. Neurol. 60(12), 1696-1702 (2003).
    • (2003) Arch. Neurol , vol.60 , Issue.12 , pp. 1696-1702
    • Clark, C.M.1    Xie, S.2    Chittams, J.3
  • 102
    • 0031583947 scopus 로고    scopus 로고
    • The level of cerebrospinal fluid Tau correlates with neurofibrillary tangles in Alzheimer's disease
    • Tapiola T, Overmyer M, Lehtovirta M et al.: The level of cerebrospinal fluid Tau correlates with neurofibrillary tangles in Alzheimer's disease. Neuroreport 8(18), 3961-3963 (1997).
    • (1997) Neuroreport , vol.8 , Issue.18 , pp. 3961-3963
    • Tapiola, T.1    Overmyer, M.2    Lehtovirta, M.3
  • 103
    • 33747689817 scopus 로고    scopus 로고
    • CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
    • Sanchez-Juan P, Green A, Ladogana A et al.: CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 67(4), 637-643 (2006).
    • (2006) Neurology , vol.67 , Issue.4 , pp. 637-643
    • Sanchez-Juan, P.1    Green, A.2    Ladogana, A.3
  • 105
    • 20444494388 scopus 로고    scopus 로고
    • Cerebrospinal fluid levels of markers of brain parenchymal damage in Vietnamese adults with severe malaria
    • Medana IM, Lindert RB, Wurster U et al.: Cerebrospinal fluid levels of markers of brain parenchymal damage in Vietnamese adults with severe malaria. Trans. R. Soc. Trop. Med. Hyg. 99(8), 610-617 (2005).
    • (2005) Trans. R. Soc. Trop. Med. Hyg , vol.99 , Issue.8 , pp. 610-617
    • Medana, I.M.1    Lindert, R.B.2    Wurster, U.3
  • 106
    • 44349095753 scopus 로고    scopus 로고
    • Elevated cerebrospinal fluid Tau protein levels in Wernicke's encephalopathy
    • Matsushita S, Miyakawa T, Maesato H et al.: Elevated cerebrospinal fluid Tau protein levels in Wernicke's encephalopathy. Alcohol. Clin. Exp. Res. 32(6), 1091-1095 (2008).
    • (2008) Alcohol. Clin. Exp. Res , vol.32 , Issue.6 , pp. 1091-1095
    • Matsushita, S.1    Miyakawa, T.2    Maesato, H.3
  • 108
    • 43249106998 scopus 로고    scopus 로고
    • CSF biomarkers in frontotemporal lobar degeneration with known pathology
    • Bian H, Van Swieten JC, Leight S et al.: CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 70(19 Pt 2), 1827-1835 (2008).
    • (2008) Neurology , vol.70 , Issue.19 PART 2 , pp. 1827-1835
    • Bian, H.1    Van Swieten, J.C.2    Leight, S.3
  • 109
    • 20944439059 scopus 로고    scopus 로고
    • Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease
    • Grossman M, Farmer J, Leight S et al.: Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann. Neurol. 57(5), 721-729 (2005).
    • (2005) Ann. Neurol , vol.57 , Issue.5 , pp. 721-729
    • Grossman, M.1    Farmer, J.2    Leight, S.3
  • 110
    • 4344580599 scopus 로고    scopus 로고
    • CSF Tau and Aβ42 are not useful in the diagnosis of frontotemporal lobar degeneration
    • Pijnenburg YA, Schoonenboom NS, Rosso SM et al.: CSF Tau and Aβ42 are not useful in the diagnosis of frontotemporal lobar degeneration. Neurology 62(9), 1649 (2004).
    • (2004) Neurology , vol.62 , Issue.9 , pp. 1649
    • Pijnenburg, Y.A.1    Schoonenboom, N.S.2    Rosso, S.M.3
  • 111
    • 47049100511 scopus 로고    scopus 로고
    • Cerebrospinal fluid biomarkers in parkinson's disease with dementia and dementia with lewy Bodies
    • Parnetti L, Tiraboschi P, Lanari A et al.: Cerebrospinal fluid biomarkers in parkinson's disease with dementia and dementia with lewy Bodies. Biol. Psychiatry (2008)
    • (2008) Biol. Psychiatry
    • Parnetti, L.1    Tiraboschi, P.2    Lanari, A.3
  • 112
    • 20644469257 scopus 로고    scopus 로고
    • Tau protein, Aβ42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies
    • Mollenhauer B, Cepek L, Bibl M et al.: Tau protein, Aβ42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies. Dement. Geriatr. Cogn. Disord. 19(2-3), 164-170 (2005).
    • (2005) Dement. Geriatr. Cogn. Disord , vol.19 , Issue.2-3 , pp. 164-170
    • Mollenhauer, B.1    Cepek, L.2    Bibl, M.3
  • 113
    • 33750455449 scopus 로고    scopus 로고
    • CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies
    • Bibl M, Mollenhauer B, Esselmann H et al.: CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies. J. Neural Transm. 113(11), 1771-1778 (2006).
    • (2006) J. Neural Transm , vol.113 , Issue.11 , pp. 1771-1778
    • Bibl, M.1    Mollenhauer, B.2    Esselmann, H.3
  • 114
    • 0035957114 scopus 로고    scopus 로고
    • Decreased CSF amyloid β42 and normal Tau levels in dementia with Lewy bodies
    • Tschampa HJ, Schulz-Schaeffer W, Wiltfang J et al.: Decreased CSF amyloid β42 and normal Tau levels in dementia with Lewy bodies. Neurology 56(4), 576 (2001).
    • (2001) Neurology , vol.56 , Issue.4 , pp. 576
    • Tschampa, H.J.1    Schulz-Schaeffer, W.2    Wiltfang, J.3
  • 115
    • 33748163112 scopus 로고    scopus 로고
    • β-amlyoid 1-42 and Tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia
    • Mollenhauer B, Trenkwalder C, von Ahsen N et al.: β-amlyoid 1-42 and Tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia. Dement. Geriatr. Cogn. Disord. 22(3), 200-208 (2006).
    • (2006) Dement. Geriatr. Cogn. Disord , vol.22 , Issue.3 , pp. 200-208
    • Mollenhauer, B.1    Trenkwalder, C.2    von Ahsen, N.3
  • 116
    • 44649192788 scopus 로고    scopus 로고
    • Pattern of Tau forms in CSF is altered in progressive supranuclear palsy
    • Borroni B, Gardoni F, Parnetti L et al.: Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol. Aging (2007)
    • (2007) Neurobiol. Aging
    • Borroni, B.1    Gardoni, F.2    Parnetti, L.3
  • 118
    • 19944434221 scopus 로고    scopus 로고
    • Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis
    • Jimenez-Jimenez FJ, Hernanz A, Medina-Acebron S et al.: Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neurol. Scand. 111(2), 114-117 (2005).
    • (2005) Acta Neurol. Scand , vol.111 , Issue.2 , pp. 114-117
    • Jimenez-Jimenez, F.J.1    Hernanz, A.2    Medina-Acebron, S.3
  • 119
    • 39449123012 scopus 로고    scopus 로고
    • Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia
    • Boban M, Grbic K, Mladinov M et al.: Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia. Coll. Antropol. 32(Suppl. 1), 31-36 (2008).
    • (2008) Coll. Antropol , vol.32 , Issue.SUPPL. 1 , pp. 31-36
    • Boban, M.1    Grbic, K.2    Mladinov, M.3
  • 120
    • 41949128622 scopus 로고    scopus 로고
    • Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis
    • Hein Née Maier K, Kohler A, Diem R et al.: Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis. Neurosci. Lett. 436(1), 72-76 (2008).
    • (2008) Neurosci. Lett , vol.436 , Issue.1 , pp. 72-76
    • Hein1    Née Maier, K.2    Kohler, A.3    Diem, R.4
  • 121
    • 20144377153 scopus 로고    scopus 로고
    • Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis
    • Brettschneider J, Maier M, Arda S et al.: Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis. Mult. Scler. 11(3), 261-265 (2005).
    • (2005) Mult. Scler , vol.11 , Issue.3 , pp. 261-265
    • Brettschneider, J.1    Maier, M.2    Arda, S.3
  • 122
    • 25144513449 scopus 로고    scopus 로고
    • CSF biomarkers for Alzheimer's disease: Use in early diagnosis and evaluation of drug treatment
    • Blennow K: CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment. Expert Rev. Mol. Diagn. 5(5), 661-672 (2005).
    • (2005) Expert Rev. Mol. Diagn , vol.5 , Issue.5 , pp. 661-672
    • Blennow, K.1
  • 123
    • 9144257234 scopus 로고    scopus 로고
    • Measurement of phosphorylated Tau epitopes in the differential diagnosis of Alzheimer disease: A comparative cerebrospinal fluid study
    • Hampel H, Buerger K, Zinkowski R et al.: Measurement of phosphorylated Tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Arch. Gen. Psychiatry 61(1), 95-102 (2004).
    • (2004) Arch. Gen. Psychiatry , vol.61 , Issue.1 , pp. 95-102
    • Hampel, H.1    Buerger, K.2    Zinkowski, R.3
  • 124
    • 0037837209 scopus 로고    scopus 로고
    • Phospho-Tau/total Tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias
    • Riemenschneider M, Wagenpfeil S, Vanderstichele H et al.: Phospho-Tau/total Tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol. Psychiatry 8(3), 343-347 (2003).
    • (2003) Mol. Psychiatry , vol.8 , Issue.3 , pp. 343-347
    • Riemenschneider, M.1    Wagenpfeil, S.2    Vanderstichele, H.3
  • 125
    • 0036182732 scopus 로고    scopus 로고
    • Decreased CSF-β-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of β-amyloid induced by disparate mechanisms
    • Sjogren M, Davidsson P, Wallin A et al.: Decreased CSF-β-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of β-amyloid induced by disparate mechanisms. Dement. Geriatr. Cogn. Disord. 13(2), 112-118 (2002).
    • (2002) Dement. Geriatr. Cogn. Disord , vol.13 , Issue.2 , pp. 112-118
    • Sjogren, M.1    Davidsson, P.2    Wallin, A.3
  • 126
    • 0036338203 scopus 로고    scopus 로고
    • Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of Tau protein phosphorylated at threonine 231
    • Buerger K, Zinkowski R, Teipel SJ et al.: Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of Tau protein phosphorylated at threonine 231. Arch. Neurol. 59(8), 1267-1272 (2002).
    • (2002) Arch. Neurol , vol.59 , Issue.8 , pp. 1267-1272
    • Buerger, K.1    Zinkowski, R.2    Teipel, S.J.3
  • 127
    • 33845713197 scopus 로고    scopus 로고
    • Analytical performance and clinical utility of the INNOTEST PHOSPHOTAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
    • Vanderstichele H, De Vreese K, Blennow K et al.: Analytical performance and clinical utility of the INNOTEST PHOSPHOTAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. Clin. Chem. Lab. Med. 44(12), 1472-1480 (2006).
    • (2006) Clin. Chem. Lab. Med , vol.44 , Issue.12 , pp. 1472-1480
    • Vanderstichele, H.1    De Vreese, K.2    Blennow, K.3
  • 129
    • 10744229989 scopus 로고    scopus 로고
    • Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total Tau
    • Lewczuk P, Esselmann H, Otto M et al.: Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total Tau. Neurobiol. Aging 25(3), 273-281 (2004).
    • (2004) Neurobiol. Aging , vol.25 , Issue.3 , pp. 273-281
    • Lewczuk, P.1    Esselmann, H.2    Otto, M.3
  • 130
    • 33745225239 scopus 로고    scopus 로고
    • Stability of CSF β-amyloid(1-42) and Tau levels by APOE genotype in Alzheimer patients
    • Huey ED, Mirza N, Putnam KT et al.: Stability of CSF β-amyloid(1-42) and Tau levels by APOE genotype in Alzheimer patients. Dement. Geriatr. Cogn. Disord. 22(1), 48-53 (2006).
    • (2006) Dement. Geriatr. Cogn. Disord , vol.22 , Issue.1 , pp. 48-53
    • Huey, E.D.1    Mirza, N.2    Putnam, K.T.3
  • 131
    • 33644532549 scopus 로고    scopus 로고
    • Towards compendia of negative genetic association studies: An example for Alzheimer disease
    • Blomqvist ME, Reynolds C, Katzov H et al.: Towards compendia of negative genetic association studies: an example for Alzheimer disease. Hum. Genet. 119(1-2), 29-37 (2006).
    • (2006) Hum. Genet , vol.119 , Issue.1-2 , pp. 29-37
    • Blomqvist, M.E.1    Reynolds, C.2    Katzov, H.3
  • 132
    • 23844537812 scopus 로고    scopus 로고
    • TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease
    • Johansson A, Zetterberg H, Hakansson A, Nissbrandt H, Blennow K: TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease. Neurodegener. Dis. 2(1), 28-35 (2005).
    • (2005) Neurodegener. Dis , vol.2 , Issue.1 , pp. 28-35
    • Johansson, A.1    Zetterberg, H.2    Hakansson, A.3    Nissbrandt, H.4    Blennow, K.5
  • 133
    • 45849122478 scopus 로고    scopus 로고
    • Variation in MAPT is associated with cerebrospinal fluid Tau levels in the presence of amyloid-β deposition
    • Kauwe JS, Cruchaga C, Mayo K et al.: Variation in MAPT is associated with cerebrospinal fluid Tau levels in the presence of amyloid-β deposition. Proc. Natl Acad. Sci. USA 105(23), 8050-8054 (2008).
    • (2008) Proc. Natl Acad. Sci. USA , vol.105 , Issue.23 , pp. 8050-8054
    • Kauwe, J.S.1    Cruchaga, C.2    Mayo, K.3
  • 134
    • 0031951155 scopus 로고    scopus 로고
    • CSF Tau is related to apolipoprotein E genotype in early Alzheimer's disease
    • Tapiola T, Lehtovirta M, Ramberg J et al.: CSF Tau is related to apolipoprotein E genotype in early Alzheimer's disease. Neurology 50(1), 169-174 (1998).
    • (1998) Neurology , vol.50 , Issue.1 , pp. 169-174
    • Tapiola, T.1    Lehtovirta, M.2    Ramberg, J.3
  • 135
    • 0033607601 scopus 로고    scopus 로고
    • Tau and apo E in CSF: Potential aid for discriminating Alzheimer's disease from other dementias
    • Molina L, Touchon J, Herpe M et al.: Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias. Neuroreport 10(17), 3491-3495 (1999).
    • (1999) Neuroreport , vol.10 , Issue.17 , pp. 3491-3495
    • Molina, L.1    Touchon, J.2    Herpe, M.3
  • 136
    • 0343471538 scopus 로고    scopus 로고
    • Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease
    • Golombowski S, Muller-Spahn F, Romig H, Mendla K, Hock C: Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease. Neurosci. Lett. 225(3), 213-215 (1997).
    • (1997) Neurosci. Lett , vol.225 , Issue.3 , pp. 213-215
    • Golombowski, S.1    Muller-Spahn, F.2    Romig, H.3    Mendla, K.4    Hock, C.5
  • 137
    • 0031971616 scopus 로고    scopus 로고
    • The role of apolipoprotein E testing in the diagnosis of Alzheimer's disease
    • Galasko D: The role of apolipoprotein E testing in the diagnosis of Alzheimer's disease. West. J. Med. 168(4), 264-265 (1998).
    • (1998) West. J. Med , vol.168 , Issue.4 , pp. 264-265
    • Galasko, D.1
  • 138
    • 34247496428 scopus 로고    scopus 로고
    • Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease
    • Laws SM, Friedrich P, Diehl-Schmid J et al.: Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease. Mol. Psychiatry 12(5), 510-517 (2007).
    • (2007) Mol. Psychiatry , vol.12 , Issue.5 , pp. 510-517
    • Laws, S.M.1    Friedrich, P.2    Diehl-Schmid, J.3
  • 140
    • 34347242354 scopus 로고    scopus 로고
    • Kinesin gene variability may affect Tau phosphorylation in early Alzheimer's disease
    • Andersson ME, Sjolander A, Andreasen N et al.: Kinesin gene variability may affect Tau phosphorylation in early Alzheimer's disease. Int. J. Mol. Med. 20(2), 233-239 (2007).
    • (2007) Int. J. Mol. Med , vol.20 , Issue.2 , pp. 233-239
    • Andersson, M.E.1    Sjolander, A.2    Andreasen, N.3
  • 141
    • 34447322271 scopus 로고    scopus 로고
    • Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria
    • Dubois B, Feldman HH, Jacova C et al.: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6(8), 734-746 (2007).
    • (2007) Lancet Neurol , vol.6 , Issue.8 , pp. 734-746
    • Dubois, B.1    Feldman, H.H.2    Jacova, C.3
  • 142
    • 17044430985 scopus 로고    scopus 로고
    • CSF biomarkers for mild cognitive impairment and early Alzheimer's disease
    • Andreasen N, Blennow K: CSF biomarkers for mild cognitive impairment and early Alzheimer's disease. Clin. Neurol. Neurosurg. 107(3), 165-173 (2005).
    • (2005) Clin. Neurol. Neurosurg , vol.107 , Issue.3 , pp. 165-173
    • Andreasen, N.1    Blennow, K.2
  • 143
    • 0037244487 scopus 로고    scopus 로고
    • Cerebrospinal fluid levels of total-Tau, phospho-Tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment
    • Andreasen N, Vanmechelen E, Vanderstichele H, Davidsson P, Blennow K: Cerebrospinal fluid levels of total-Tau, phospho-Tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment. Acta Neurol. Scand. Suppl. 179, 47-51 (2003).
    • (2003) Acta Neurol. Scand. Suppl , vol.179 , pp. 47-51
    • Andreasen, N.1    Vanmechelen, E.2    Vanderstichele, H.3    Davidsson, P.4    Blennow, K.5
  • 144
    • 37349026227 scopus 로고    scopus 로고
    • Multicenter assessment of CSF-phosphorylated Tau for the prediction of conversion of MCI
    • Ewers M, Buerger K, Teipel SJ et al.: Multicenter assessment of CSF-phosphorylated Tau for the prediction of conversion of MCI. Neurology 69(24), 2205-2212 (2007).
    • (2007) Neurology , vol.69 , Issue.24 , pp. 2205-2212
    • Ewers, M.1    Buerger, K.2    Teipel, S.J.3
  • 145
    • 0037183481 scopus 로고    scopus 로고
    • CSF Tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects
    • Buerger K, Teipel SJ, Zinkowski R et al.: CSF Tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology 59(4), 627-629 (2002).
    • (2002) Neurology , vol.59 , Issue.4 , pp. 627-629
    • Buerger, K.1    Teipel, S.J.2    Zinkowski, R.3
  • 146
    • 31844440459 scopus 로고    scopus 로고
    • Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment
    • de Leon MJ, DeSanti S, Zinkowski R et al.: Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol. Aging 27(3), 394-401 (2006).
    • (2006) Neurobiol. Aging , vol.27 , Issue.3 , pp. 394-401
    • de Leon, M.J.1    DeSanti, S.2    Zinkowski, R.3
  • 147
    • 32544435900 scopus 로고    scopus 로고
    • Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study
    • Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 5(3), 228-234 (2006).
    • (2006) Lancet Neurol , vol.5 , Issue.3 , pp. 228-234
    • Hansson, O.1    Zetterberg, H.2    Buchhave, P.3    Londos, E.4    Blennow, K.5    Minthon, L.6
  • 148
    • 16844382811 scopus 로고    scopus 로고
    • CSF Aβ42 and Tau or phosphorylated Tau and prediction of progressive mild cognitive impairment
    • Herukka SK, Hallikainen M, Soininen H, Pirttila T: CSF Aβ42 and Tau or phosphorylated Tau and prediction of progressive mild cognitive impairment. Neurology 64(7), 1294-1297 (2005).
    • (2005) Neurology , vol.64 , Issue.7 , pp. 1294-1297
    • Herukka, S.K.1    Hallikainen, M.2    Soininen, H.3    Pirttila, T.4
  • 150
    • 38049036228 scopus 로고    scopus 로고
    • Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
    • Brys M, Pirraglia E, Rich K et al.: Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiol. Aging (2007)
    • (2007) Neurobiol. Aging
    • Brys, M.1    Pirraglia, E.2    Rich, K.3
  • 151
    • 0042512345 scopus 로고    scopus 로고
    • Mild cognitive impairment: Prevalence, prognosis, aetiology, and treatment
    • DeCarli C: Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol. 2(1), 15-21 (2003).
    • (2003) Lancet Neurol , vol.2 , Issue.1 , pp. 15-21
    • DeCarli, C.1
  • 152
    • 47549117283 scopus 로고    scopus 로고
    • Biochemical markers in persons with preclinical familial Alzheimer disease
    • Ringman JM, Younkin SG, Pratico D et al.: Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology 71(2), 85-92 (2008).
    • (2008) Neurology , vol.71 , Issue.2 , pp. 85-92
    • Ringman, J.M.1    Younkin, S.G.2    Pratico, D.3
  • 153
    • 2442586536 scopus 로고    scopus 로고
    • Tau protein in cerebrospinal fluid: A possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis
    • Martinez-Yelamos A, Saiz A, Bas J, Hernandez JJ, Graus F, Arbizu T: Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis. Neurosci. Lett. 363(1), 14-17 (2004).
    • (2004) Neurosci. Lett , vol.363 , Issue.1 , pp. 14-17
    • Martinez-Yelamos, A.1    Saiz, A.2    Bas, J.3    Hernandez, J.J.4    Graus, F.5    Arbizu, T.6
  • 154
    • 33750376704 scopus 로고    scopus 로고
    • CSF Tau protein: A new prognostic marker for Guillain-Barre syndrome
    • Jin K, Takeda A, Shiga Y et al.: CSF Tau protein: a new prognostic marker for Guillain-Barre syndrome. Neurology 67(8), 1470-1472 (2006).
    • (2006) Neurology , vol.67 , Issue.8 , pp. 1470-1472
    • Jin, K.1    Takeda, A.2    Shiga, Y.3
  • 155
    • 33750999347 scopus 로고    scopus 로고
    • Initial CSF total Tau correlates with 1-year outcome in patients with traumatic brain injury
    • Ost M, Nylen K, Csajbok L et al.: Initial CSF total Tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 67(9), 1600-1604 (2006).
    • (2006) Neurology , vol.67 , Issue.9 , pp. 1600-1604
    • Ost, M.1    Nylen, K.2    Csajbok, L.3
  • 156
    • 36549078600 scopus 로고    scopus 로고
    • Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years
    • Zetterberg H, Pedersen M, Lind K et al.: Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years. J. Alzheimers Dis. 12(3), 255-260 (2007).
    • (2007) J. Alzheimers Dis , vol.12 , Issue.3 , pp. 255-260
    • Zetterberg, H.1    Pedersen, M.2    Lind, K.3
  • 157
    • 0141738373 scopus 로고    scopus 로고
    • CSF markers for incipient Alzheimer's disease
    • Blennow K, Hampel H: CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2(10), 605-613 (2003).
    • (2003) Lancet Neurol , vol.2 , Issue.10 , pp. 605-613
    • Blennow, K.1    Hampel, H.2
  • 158
    • 1542313783 scopus 로고    scopus 로고
    • Core biological marker candidates of Alzheimer's disease: Perspectives for diagnosis, prediction of outcome and reflection of biological activity
    • Hampel H, Mitchell A, Blennow K et al.: Core biological marker candidates of Alzheimer's disease: perspectives for diagnosis, prediction of outcome and reflection of biological activity. J. Neural Transm. 111(3), 247-272 (2004).
    • (2004) J. Neural Transm , vol.111 , Issue.3 , pp. 247-272
    • Hampel, H.1    Mitchell, A.2    Blennow, K.3
  • 159
    • 21244457198 scopus 로고    scopus 로고
    • Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia
    • Wiltfang J, Lewczuk P, Riederer P et al.: Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J. Biol. Psychiatryy 6(2), 69-84 (2005).
    • (2005) World J. Biol. Psychiatryy , vol.6 , Issue.2 , pp. 69-84
    • Wiltfang, J.1    Lewczuk, P.2    Riederer, P.3
  • 160
    • 44949219321 scopus 로고    scopus 로고
    • Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
    • Engelborghs S, De Vreese K, Van de Casteele T et al.: Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol. Aging 29(8), 1143-1159 (2008).
    • (2008) Neurobiol. Aging , vol.29 , Issue.8 , pp. 1143-1159
    • Engelborghs, S.1    De Vreese, K.2    Van de Casteele, T.3
  • 161
    • 34548450659 scopus 로고    scopus 로고
    • Longitudinal changes of CSF biomarkers in memory clinic patients
    • Bouwman FH, van der Flier WM, Schoonenboom NS et al.: Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology 69(10), 1006-1011 (2007).
    • (2007) Neurology , vol.69 , Issue.10 , pp. 1006-1011
    • Bouwman, F.H.1    van der Flier, W.M.2    Schoonenboom, N.S.3
  • 162
    • 54849419105 scopus 로고    scopus 로고
    • The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease
    • Bahl JM, Heegaard NH, Falkenhorst G et al.: The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease. Neurobiol. Aging (2008)
    • (2008) Neurobiol. Aging
    • Bahl, J.M.1    Heegaard, N.H.2    Falkenhorst, G.3
  • 163
    • 22144434340 scopus 로고    scopus 로고
    • Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease
    • Van Everbroeck B, Boons J, Cras P: Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin. Neurol. Neurosurg. 107(5), 355-360 (2005).
    • (2005) Clin. Neurol. Neurosurg , vol.107 , Issue.5 , pp. 355-360
    • Van Everbroeck, B.1    Boons, J.2    Cras, P.3
  • 164
    • 0035100888 scopus 로고    scopus 로고
    • Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
    • Atkinson AJ: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89-95 (2001).
    • (2001) Clin. Pharmacol. Ther , vol.69 , pp. 89-95
    • Atkinson, A.J.1
  • 165
    • 33947223454 scopus 로고    scopus 로고
    • Cerebrospinal fluid Tau/β-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults
    • Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM: Cerebrospinal fluid Tau/β-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch. Neurol. 64(3), 343-349 (2007).
    • (2007) Arch. Neurol , vol.64 , Issue.3 , pp. 343-349
    • Fagan, A.M.1    Roe, C.M.2    Xiong, C.3    Mintun, M.A.4    Morris, J.C.5    Holtzman, D.M.6
  • 166
    • 32044436030 scopus 로고    scopus 로고
    • CSF biomarkers for Alzheimer's disease: Levels of β-amyloid, Tau, phosphorylated Tau relate to clinical symptoms and survival
    • Wallin AK, Blennow K, Andreasen N, Minthon L: CSF biomarkers for Alzheimer's disease: levels of β-amyloid, Tau, phosphorylated Tau relate to clinical symptoms and survival. Dement. Geriatr. Cogn. Disord. 21(3), 131-138 (2006).
    • (2006) Dement. Geriatr. Cogn. Disord , vol.21 , Issue.3 , pp. 131-138
    • Wallin, A.K.1    Blennow, K.2    Andreasen, N.3    Minthon, L.4
  • 167
    • 49649124175 scopus 로고    scopus 로고
    • Increasing CSF phospho-Tau levels during cognitive decline and progression to dementia
    • Andersson C, Blennow K, Almkvist O et al.: Increasing CSF phospho-Tau levels during cognitive decline and progression to dementia. Neurobiol. Aging (2007)
    • (2007) Neurobiol. Aging
    • Andersson, C.1    Blennow, K.2    Almkvist, O.3
  • 168
    • 0037457354 scopus 로고    scopus 로고
    • Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients
    • Wahlund LO, Blennow K: Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients. Neurosci. Lett. 339(2), 99-102 (2003).
    • (2003) Neurosci. Lett , vol.339 , Issue.2 , pp. 99-102
    • Wahlund, L.O.1    Blennow, K.2
  • 169
    • 47849108205 scopus 로고    scopus 로고
    • CSF Aβ42 Tau and phosphorylated Tau correlate with medial temporal lobe atrophy
    • Herukka SK, Pennanen C, Soininen H, Pirttila T: CSF Aβ42 Tau and phosphorylated Tau correlate with medial temporal lobe atrophy. J. Alzheimers Dis. 14(1), 51-57 (2008).
    • (2008) J. Alzheimers Dis , vol.14 , Issue.1 , pp. 51-57
    • Herukka, S.K.1    Pennanen, C.2    Soininen, H.3    Pirttila, T.4
  • 170
    • 54849414660 scopus 로고    scopus 로고
    • Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years
    • Stomrud E, Hansson O, Minthon L, Blennow K, Rosen I, Londos E: Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years. Neurobiol. Aging (2008)
    • (2008) Neurobiol. Aging
    • Stomrud, E.1    Hansson, O.2    Minthon, L.3    Blennow, K.4    Rosen, I.5    Londos, E.6
  • 171
    • 20444388706 scopus 로고    scopus 로고
    • Microtubule-associated protein Tau: A marker of paclitaxel sensitivity in breast cancer
    • Rouzier R, Rajan R, Wagner P et al.: Microtubule-associated protein Tau: a marker of paclitaxel sensitivity in breast cancer. Proc. Natl Acad. Sci. USA 102(23), 8315-8320 (2005).
    • (2005) Proc. Natl Acad. Sci. USA , vol.102 , Issue.23 , pp. 8315-8320
    • Rouzier, R.1    Rajan, R.2    Wagner, P.3
  • 172
    • 2442642836 scopus 로고    scopus 로고
    • Retarded axonal transport of R406W mutant Tau in transgenic mice with a neurodegenerative tauopathy
    • Zhang B, Higuchi M, Yoshiyama Y et al.: Retarded axonal transport of R406W mutant Tau in transgenic mice with a neurodegenerative tauopathy. J. Neurosci. 24(19), 4657-4667 (2004).
    • (2004) J. Neurosci , vol.24 , Issue.19 , pp. 4657-4667
    • Zhang, B.1    Higuchi, M.2    Yoshiyama, Y.3
  • 173
    • 0141867804 scopus 로고    scopus 로고
    • Quantification and localization of kainic acid-induced neurotoxicity employing a new biomarker of cell death: Cleaved microtubule-associated protein-Tau (C-Tau)
    • Zemlan FP, Mulchahey JJ, Gudelsky GA: Quantification and localization of kainic acid-induced neurotoxicity employing a new biomarker of cell death: cleaved microtubule-associated protein-Tau (C-Tau). Neuroscience 121(2), 399-409 (2003).
    • (2003) Neuroscience , vol.121 , Issue.2 , pp. 399-409
    • Zemlan, F.P.1    Mulchahey, J.J.2    Gudelsky, G.A.3
  • 174
    • 52049096219 scopus 로고    scopus 로고
    • Characterization of Tau in cerebrospinal fluid using mass spectrometry
    • Portelius E, Hansson SF, Tran AJ et al.: Characterization of Tau in cerebrospinal fluid using mass spectrometry. J. Proteome Res. 7(5), 2114-2120 (2008).
    • (2008) J. Proteome Res , vol.7 , Issue.5 , pp. 2114-2120
    • Portelius, E.1    Hansson, S.F.2    Tran, A.J.3
  • 175
    • 37449000878 scopus 로고    scopus 로고
    • Detection of Alzheimer's Tau protein using localised surface plasmon resonance-based immunochip
    • Vestergaard M, Kerman K, Kim DK, Ha MH, Tamiya E: Detection of Alzheimer's Tau protein using localised surface plasmon resonance-based immunochip. Talanta 74(4), 1038-1042 (2008).
    • (2008) Talanta , vol.74 , Issue.4 , pp. 1038-1042
    • Vestergaard, M.1    Kerman, K.2    Kim, D.K.3    Ha, M.H.4    Tamiya, E.5
  • 176
    • 33644864034 scopus 로고    scopus 로고
    • Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study
    • States DJ, Omenn GS, Blackwell TW et al.: Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol. 24(3), 333-338 (2006).
    • (2006) Nat. Biotechnol , vol.24 , Issue.3 , pp. 333-338
    • States, D.J.1    Omenn, G.S.2    Blackwell, T.W.3
  • 177
    • 19044376179 scopus 로고    scopus 로고
    • Serum Tau protein level as a marker of axonal damage in acute ischemic stroke
    • Bitsch A, Horn C, Kemmling Y et al.: Serum Tau protein level as a marker of axonal damage in acute ischemic stroke. Eur. Neurol. 47(1), 45-51 (2002).
    • (2002) Eur. Neurol , vol.47 , Issue.1 , pp. 45-51
    • Bitsch, A.1    Horn, C.2    Kemmling, Y.3
  • 178
    • 33746929545 scopus 로고    scopus 로고
    • Neuron-specific enolase and Tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke
    • Wunderlich MT, Lins H, Skalej M, Wallesch CW, Goertler M: Neuron-specific enolase and Tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin. Neurol. Neurosurg. 108(6), 558-563 (2006).
    • (2006) Clin. Neurol. Neurosurg , vol.108 , Issue.6 , pp. 558-563
    • Wunderlich, M.T.1    Lins, H.2    Skalej, M.3    Wallesch, C.W.4    Goertler, M.5
  • 179
    • 0037154135 scopus 로고    scopus 로고
    • Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
    • Otto M, Wiltfang J, Cepek L et al.: Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58(2), 192-197 (2002).
    • (2002) Neurology , vol.58 , Issue.2 , pp. 192-197
    • Otto, M.1    Wiltfang, J.2    Cepek, L.3
  • 180
    • 0036126040 scopus 로고    scopus 로고
    • Serum cleaved Tau protein levels and clinical outcome in adult patients with closed head injury
    • Shaw GJ, Jauch EC, Zemlan FP: Serum cleaved Tau protein levels and clinical outcome in adult patients with closed head injury. Ann. Emerg. Med. 39(3), 254-257 (2002).
    • (2002) Ann. Emerg. Med , vol.39 , Issue.3 , pp. 254-257
    • Shaw, G.J.1    Jauch, E.C.2    Zemlan, F.P.3
  • 181
    • 0037162967 scopus 로고    scopus 로고
    • C-Tau biomarker of neuronal damage in severe brain injured patients: Association with elevated intracranial pressure and clinical outcome
    • Zemlan FP, Jauch EC, Mulchahey JJ et al.: C-Tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 947(1), 131-139 (2002).
    • (2002) Brain Res , vol.947 , Issue.1 , pp. 131-139
    • Zemlan, F.P.1    Jauch, E.C.2    Mulchahey, J.J.3
  • 182
    • 18744406008 scopus 로고    scopus 로고
    • Discordant temporal patterns of S100β and cleaved Tau protein elevation after head injury: A pilot study
    • Chatfield DA, Zemlan FP, Day DJ, Menon DK: Discordant temporal patterns of S100β and cleaved Tau protein elevation after head injury: a pilot study. Br. J. Neurosurg. 16(5), 471-476 (2002).
    • (2002) Br. J. Neurosurg , vol.16 , Issue.5 , pp. 471-476
    • Chatfield, D.A.1    Zemlan, F.P.2    Day, D.J.3    Menon, D.K.4
  • 183
    • 0036107977 scopus 로고    scopus 로고
    • Levels of nonphosphorylated and phosphorylated Tau in cerebrospinal fluid of Alzheimer's disease patients: An ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay
    • Hu YY, He SS, Wang X et al.: Levels of nonphosphorylated and phosphorylated Tau in cerebrospinal fluid of Alzheimer's disease patients: an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. Am. J. Pathol. 160(4), 1269-1278 (2002).
    • (2002) Am. J. Pathol , vol.160 , Issue.4 , pp. 1269-1278
    • Hu, Y.Y.1    He, S.S.2    Wang, X.3
  • 184
    • 14444269228 scopus 로고    scopus 로고
    • Longitudinal study of cerebrospinal fluid levels of Tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease: A study in Japan
    • Kanai M, Matsubara E, Isoe K et al.: Longitudinal study of cerebrospinal fluid levels of Tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease: a study in Japan. Ann. Neurol. 44(1), 17-26 (1998).
    • (1998) Ann. Neurol , vol.44 , Issue.1 , pp. 17-26
    • Kanai, M.1    Matsubara, E.2    Isoe, K.3
  • 185
    • 0032693829 scopus 로고    scopus 로고
    • Sensitivity, specificity, and stability of CSF-Tau in AD in a community-based patient sample
    • Andreasen N, Minthon L, Clarberg A et al.: Sensitivity, specificity, and stability of CSF-Tau in AD in a community-based patient sample. Neurology 53(7), 1488-1494 (1999).
    • (1999) Neurology , vol.53 , Issue.7 , pp. 1488-1494
    • Andreasen, N.1    Minthon, L.2    Clarberg, A.3
  • 186
    • 0032821266 scopus 로고    scopus 로고
    • Longitudinal stability of CSF Tau levels in Alzheimer patients
    • Sunderland T, Wolozin B, Galasko D et al.: Longitudinal stability of CSF Tau levels in Alzheimer patients. Biol. Psychiatry 46(6), 750-755 (1999).
    • (1999) Biol. Psychiatry , vol.46 , Issue.6 , pp. 750-755
    • Sunderland, T.1    Wolozin, B.2    Galasko, D.3
  • 187
    • 34247893817 scopus 로고    scopus 로고
    • Longitudinal stability of CSF biomarkers in Alzheimer's disease
    • Blennow K, Zetterberg H, Minthon L et al.: Longitudinal stability of CSF biomarkers in Alzheimer's disease. Neurosci. Lett. 419(1), 18-22 (2007).
    • (2007) Neurosci. Lett , vol.419 , Issue.1 , pp. 18-22
    • Blennow, K.1    Zetterberg, H.2    Minthon, L.3
  • 188
    • 34547679856 scopus 로고    scopus 로고
    • Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis
    • Sanchez-Juan P, Sanchez-Valle R, Green A et al.: Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J. Neurol. 254(7), 901-906 (2007).
    • (2007) J. Neurol , vol.254 , Issue.7 , pp. 901-906
    • Sanchez-Juan, P.1    Sanchez-Valle, R.2    Green, A.3
  • 189
    • 0035910638 scopus 로고    scopus 로고
    • Transient increase in total Tau but not phospho-Tau in human cerebrospinal fluid after acute stroke
    • Hesse C, Rosengren L, Andreasen N et al.: Transient increase in total Tau but not phospho-Tau in human cerebrospinal fluid after acute stroke. Neurosci. Lett. 297(3), 187-190 (2001).
    • (2001) Neurosci. Lett , vol.297 , Issue.3 , pp. 187-190
    • Hesse, C.1    Rosengren, L.2    Andreasen, N.3
  • 190
    • 0034517797 scopus 로고    scopus 로고
    • Disease- and treatment-related elevation of the neurodegenerative marker Tau in children with hematological malignancies
    • Van Gool SW, Van Kerschaver E, Brock P et al.: Disease- and treatment-related elevation of the neurodegenerative marker Tau in children with hematological malignancies. Leukemia 14(12), 2076-2084 (2000).
    • (2000) Leukemia , vol.14 , Issue.12 , pp. 2076-2084
    • Van Gool, S.W.1    Van Kerschaver, E.2    Brock, P.3
  • 191
    • 18744417222 scopus 로고    scopus 로고
    • Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors
    • Parnetti L, Amici S, Lanari A et al.: Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors. Neurol. Sci. 23(Suppl. 2), S95-S96 (2002).
    • (2002) Neurol. Sci , vol.23 , Issue.SUPPL. 2
    • Parnetti, L.1    Amici, S.2    Lanari, A.3
  • 193
    • 20944448555 scopus 로고    scopus 로고
    • Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
    • Gilman S, Koller M, Black RS et al.: Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64(9), 1553-1562 (2005).
    • (2005) Neurology , vol.64 , Issue.9 , pp. 1553-1562
    • Gilman, S.1    Koller, M.2    Black, R.S.3
  • 194
    • 33847006236 scopus 로고    scopus 로고
    • Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid
    • Riekse RG, Li G, Petrie EC et al.: Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. J. Alzheimers Dis. 10(4), 399-406 (2006).
    • (2006) J. Alzheimers Dis , vol.10 , Issue.4 , pp. 399-406
    • Riekse, R.G.1    Li, G.2    Petrie, E.C.3
  • 195
    • 15244363203 scopus 로고    scopus 로고
    • Association between Tau H2 haplotype and age at onset in frontotemporal dementia
    • Borroni B, Yancopoulou D, Tsutsui M et al.: Association between Tau H2 haplotype and age at onset in frontotemporal dementia. Arch. Neurol. 62(9), 1419-1422 (2005).
    • (2005) Arch. Neurol , vol.62 , Issue.9 , pp. 1419-1422
    • Borroni, B.1    Yancopoulou, D.2    Tsutsui, M.3
  • 196
    • 19944429064 scopus 로고    scopus 로고
    • Microtubule-binding drugs offset Tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model
    • Zhang B, Maiti A, Shively S et al.: Microtubule-binding drugs offset Tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc. Natl Acad. Sci. USA 102(1), 227-231 (2005).
    • (2005) Proc. Natl Acad. Sci. USA , vol.102 , Issue.1 , pp. 227-231
    • Zhang, B.1    Maiti, A.2    Shively, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.